The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / KeMo Disease: A Newly Recognized Debilitating Musculoskeletal Disease

KeMo Disease: A Newly Recognized Debilitating Musculoskeletal Disease

September 15, 2015 • By John F. Beary, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Dr. Simon Helfgott’s essay, “Barking at the Moon,” in the July 2015 issue of The Rheumatologist, about the unintended consequences of EHRs (electronic health records) prompted me to share my experience regarding the newly recognized KeMo disease.

You Might Also Like
  • Mesenchymal Stem Cell Therapy May Help Slow, Repair Degenerative Signs of Osteoarthritis, Musculoskeletal Disease
  • Clinical Guidelines for Sjögren’s Syndrome Focus on Biologics, Fatigue, Inflammatory Musculoskeletal Pain
  • Newly Diagnosed SLE Patients Have a Greater Risk of Cardiovascular Disease
Explore This Issue
September 2015

Keyboarding and mouse-clicking (KeMo) activity now consumes about 50% of the medical clinician’s day, as the modern EHRs are installed and the Medicare Meaningful Use and ICD-10 coding regulations are enforced. As Dr. Helfgott notes, dogs can learn to fetch sticks much quicker than doctors can learn the new documentation and coding procedures demanded by Medicare.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

KeMo has diffuse, adverse effects on the human musculoskeletal system. (Dogs have not yet learned to efficiently keyboard, to my knowledge.) My physician colleagues are suffering from a variety of overuse syndromes such as carpal tunnel syndrome; thumb osteoarthritis and tendinitis; and lateral elbow epicondylitis. They can be spotted in the hallways with their wrist splints, elbow braces and neck collars. Four hours of sitting and keyboarding daily are likely to create an epidemic of low back pain, swollen feet and metabolic syndrome. Clearly, additional research will be needed to see what corrective measures can be taken, until doctors are replaced by robots.

Health system CEOs tell us that KeMo is necessary to cure the malignant cost and quality problems that are afflicting modern medicine. KeMo will make you feel poorly, and you will experience some suffering in the short term. However, over time KeMo will cure all of your problems, and you will feel wonderful.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Sincerely,
John F. Beary, MD
Clinical Professor of Medicine/Rheumatology
University of Cincinnati School of Medicine
Cincinnati

Filed Under: Conditions, Electronic Health Records, Technology Tagged With: Clinical, EHR, electronic health record, KeMo Disease, musculoskeletal disease, patient care, TreatmentIssue: September 2015

You Might Also Like:
  • Mesenchymal Stem Cell Therapy May Help Slow, Repair Degenerative Signs of Osteoarthritis, Musculoskeletal Disease
  • Clinical Guidelines for Sjögren’s Syndrome Focus on Biologics, Fatigue, Inflammatory Musculoskeletal Pain
  • Newly Diagnosed SLE Patients Have a Greater Risk of Cardiovascular Disease
  • The Diagnosis: How to Advise Newly Diagnosed RA Patients

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)